News

Filter

Current filters:

Yaz

1 to 9 of 51 results

Bayer updates drospirenone-containing COCs labels to reflect VTE risk

11-04-2012

Following a further review of the products by the US Food and Drug Administration , Bayer HealthCare…

BayerBeyazdrospirenoneNorth AmericaPharmaceuticalRegulationReproductiveWomen's HealthYasminYaz

Mixed views on drospirenone OCs

09-12-2011

The majority of members of the US Food and Drug Administration’s Reproductive Health Drugs Advisory…

BayerDrospirenone and EstradiolNorth AmericaPharmaceuticalRegulationReproductiveWomen's HealthYasminYaz

US FDA communicates concern about drospirenone-containing birth control pills

27-09-2011

The US Food and Drug Administration (FDA) is informing the public that it has not yet reached a conclusion,…

BayerDrospirenone and Ethinyl EstradiolNorth AmericaPharmaceuticalRegulationReproductiveYasminYaz

Two new studies find Bayer's contraceptives Yaz and Yasmin have an increased risk of blood clots

26-04-2011

According to two new studies published in the on-line edition of the British Medical Journal, German…

BayerPharmaceuticalRegulationReproductiveResearchYasminYaz

1 to 9 of 51 results

COMPANY SPOTLIGHT

Menarini

Back to top